Global Cancer Biomarker Market Insights and Forecast to 2028
Table of Contents1 Study Coverage
1.1 Cancer Biomarker Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Protein Biomarker
1.2.3 Genetic Biomarker
1.3 Market by Application
1.3.1 Global Cancer Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cancer Biomarker Sales Estimates and Forecasts 2017-2028
2.2 Global Cancer Biomarker Revenue Estimates and Forecasts 2017-2028
2.3 Global Cancer Biomarker Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cancer Biomarker Sales by Region
2.4.1 Global Cancer Biomarker Sales by Region (2017-2022)
2.4.2 Global Sales Cancer Biomarker by Region (2023-2028)
2.5 Global Cancer Biomarker Revenue by Region
2.5.1 Global Cancer Biomarker Revenue by Region (2017-2022)
2.5.2 Global Cancer Biomarker Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cancer Biomarker Sales by Manufacturers
3.1.1 Global Top Cancer Biomarker Manufacturers by Sales (2017-2022)
3.1.2 Global Cancer Biomarker Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Biomarker in 2021
3.2 Global Cancer Biomarker Revenue by Manufacturers
3.2.1 Global Cancer Biomarker Revenue by Manufacturers (2017-2022)
3.2.2 Global Cancer Biomarker Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cancer Biomarker Revenue in 2021
3.3 Global Cancer Biomarker Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cancer Biomarker Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cancer Biomarker Sales by Type
4.1.1 Global Cancer Biomarker Historical Sales by Type (2017-2022)
4.1.2 Global Cancer Biomarker Forecasted Sales by Type (2023-2028)
4.1.3 Global Cancer Biomarker Sales Market Share by Type (2017-2028)
4.2 Global Cancer Biomarker Revenue by Type
4.2.1 Global Cancer Biomarker Historical Revenue by Type (2017-2022)
4.2.2 Global Cancer Biomarker Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cancer Biomarker Revenue Market Share by Type (2017-2028)
4.3 Global Cancer Biomarker Price by Type
4.3.1 Global Cancer Biomarker Price by Type (2017-2022)
4.3.2 Global Cancer Biomarker Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cancer Biomarker Sales by Application
5.1.1 Global Cancer Biomarker Historical Sales by Application (2017-2022)
5.1.2 Global Cancer Biomarker Forecasted Sales by Application (2023-2028)
5.1.3 Global Cancer Biomarker Sales Market Share by Application (2017-2028)
5.2 Global Cancer Biomarker Revenue by Application
5.2.1 Global Cancer Biomarker Historical Revenue by Application (2017-2022)
5.2.2 Global Cancer Biomarker Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cancer Biomarker Revenue Market Share by Application (2017-2028)
5.3 Global Cancer Biomarker Price by Application
5.3.1 Global Cancer Biomarker Price by Application (2017-2022)
5.3.2 Global Cancer Biomarker Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cancer Biomarker Market Size by Type
6.1.1 North America Cancer Biomarker Sales by Type (2017-2028)
6.1.2 North America Cancer Biomarker Revenue by Type (2017-2028)
6.2 North America Cancer Biomarker Market Size by Application
6.2.1 North America Cancer Biomarker Sales by Application (2017-2028)
6.2.2 North America Cancer Biomarker Revenue by Application (2017-2028)
6.3 North America Cancer Biomarker Market Size by Country
6.3.1 North America Cancer Biomarker Sales by Country (2017-2028)
6.3.2 North America Cancer Biomarker Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cancer Biomarker Market Size by Type
7.1.1 Europe Cancer Biomarker Sales by Type (2017-2028)
7.1.2 Europe Cancer Biomarker Revenue by Type (2017-2028)
7.2 Europe Cancer Biomarker Market Size by Application
7.2.1 Europe Cancer Biomarker Sales by Application (2017-2028)
7.2.2 Europe Cancer Biomarker Revenue by Application (2017-2028)
7.3 Europe Cancer Biomarker Market Size by Country
7.3.1 Europe Cancer Biomarker Sales by Country (2017-2028)
7.3.2 Europe Cancer Biomarker Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cancer Biomarker Market Size by Type
8.1.1 Asia Pacific Cancer Biomarker Sales by Type (2017-2028)
8.1.2 Asia Pacific Cancer Biomarker Revenue by Type (2017-2028)
8.2 Asia Pacific Cancer Biomarker Market Size by Application
8.2.1 Asia Pacific Cancer Biomarker Sales by Application (2017-2028)
8.2.2 Asia Pacific Cancer Biomarker Revenue by Application (2017-2028)
8.3 Asia Pacific Cancer Biomarker Market Size by Region
8.3.1 Asia Pacific Cancer Biomarker Sales by Region (2017-2028)
8.3.2 Asia Pacific Cancer Biomarker Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cancer Biomarker Market Size by Type
9.1.1 Latin America Cancer Biomarker Sales by Type (2017-2028)
9.1.2 Latin America Cancer Biomarker Revenue by Type (2017-2028)
9.2 Latin America Cancer Biomarker Market Size by Application
9.2.1 Latin America Cancer Biomarker Sales by Application (2017-2028)
9.2.2 Latin America Cancer Biomarker Revenue by Application (2017-2028)
9.3 Latin America Cancer Biomarker Market Size by Country
9.3.1 Latin America Cancer Biomarker Sales by Country (2017-2028)
9.3.2 Latin America Cancer Biomarker Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cancer Biomarker Market Size by Type
10.1.1 Middle East and Africa Cancer Biomarker Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cancer Biomarker Revenue by Type (2017-2028)
10.2 Middle East and Africa Cancer Biomarker Market Size by Application
10.2.1 Middle East and Africa Cancer Biomarker Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cancer Biomarker Revenue by Application (2017-2028)
10.3 Middle East and Africa Cancer Biomarker Market Size by Country
10.3.1 Middle East and Africa Cancer Biomarker Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cancer Biomarker Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Overview
11.1.3 Thermo Fisher Scientific Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Thermo Fisher Scientific Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Corporation Information
11.2.2 Bio-Rad Laboratories Overview
11.2.3 Bio-Rad Laboratories Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bio-Rad Laboratories Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bio-Rad Laboratories Recent Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Corporation Information
11.3.2 Roche Diagnostics Overview
11.3.3 Roche Diagnostics Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Diagnostics Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Diagnostics Recent Developments
11.4 Qiagen
11.4.1 Qiagen Corporation Information
11.4.2 Qiagen Overview
11.4.3 Qiagen Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Qiagen Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Qiagen Recent Developments
11.5 Illumina
11.5.1 Illumina Corporation Information
11.5.2 Illumina Overview
11.5.3 Illumina Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Illumina Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Illumina Recent Developments
11.6 GE Healthcare
11.6.1 GE Healthcare Corporation Information
11.6.2 GE Healthcare Overview
11.6.3 GE Healthcare Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GE Healthcare Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GE Healthcare Recent Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Corporation Information
11.7.2 Agilent Technologies Overview
11.7.3 Agilent Technologies Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Agilent Technologies Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Agilent Technologies Recent Developments
11.8 Biomérieux SA
11.8.1 Biomérieux SA Corporation Information
11.8.2 Biomérieux SA Overview
11.8.3 Biomérieux SA Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Biomérieux SA Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biomérieux SA Recent Developments
11.9 Merck & Co.
11.9.1 Merck & Co. Corporation Information
11.9.2 Merck & Co. Overview
11.9.3 Merck & Co. Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck & Co. Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck & Co. Recent Developments
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Corporation Information
11.10.2 Abbott Laboratories Overview
11.10.3 Abbott Laboratories Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Abbott Laboratories Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abbott Laboratories Recent Developments
11.11 Becton, Dickinson and Company
11.11.1 Becton, Dickinson and Company Corporation Information
11.11.2 Becton, Dickinson and Company Overview
11.11.3 Becton, Dickinson and Company Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Becton, Dickinson and Company Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Becton, Dickinson and Company Recent Developments
11.12 Danaher Corporation
11.12.1 Danaher Corporation Corporation Information
11.12.2 Danaher Corporation Overview
11.12.3 Danaher Corporation Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Danaher Corporation Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Danaher Corporation Recent Developments
11.13 Myriad Genetics
11.13.1 Myriad Genetics Corporation Information
11.13.2 Myriad Genetics Overview
11.13.3 Myriad Genetics Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Myriad Genetics Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Myriad Genetics Recent Developments
11.14 Sysmex Corporation
11.14.1 Sysmex Corporation Corporation Information
11.14.2 Sysmex Corporation Overview
11.14.3 Sysmex Corporation Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sysmex Corporation Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sysmex Corporation Recent Developments
11.15 Hologic
11.15.1 Hologic Corporation Information
11.15.2 Hologic Overview
11.15.3 Hologic Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Hologic Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Hologic Recent Developments
11.16 Quest Diagnostics
11.16.1 Quest Diagnostics Corporation Information
11.16.2 Quest Diagnostics Overview
11.16.3 Quest Diagnostics Cancer Biomarker Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Quest Diagnostics Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Quest Diagnostics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cancer Biomarker Industry Chain Analysis
12.2 Cancer Biomarker Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cancer Biomarker Production Mode & Process
12.4 Cancer Biomarker Sales and Marketing
12.4.1 Cancer Biomarker Sales Channels
12.4.2 Cancer Biomarker Distributors
12.5 Cancer Biomarker Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cancer Biomarker Industry Trends
13.2 Cancer Biomarker Market Drivers
13.3 Cancer Biomarker Market Challenges
13.4 Cancer Biomarker Market Restraints
14 Key Findings in The Global Cancer Biomarker Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global Cancer Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Protein Biomarker
Table 3. Major Manufacturers of Genetic Biomarker
Table 4. Global Cancer Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Cancer Biomarker Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Cancer Biomarker Sales by Region (2017-2022) & (K Units)
Table 7. Global Cancer Biomarker Sales Market Share by Region (2017-2022)
Table 8. Global Cancer Biomarker Sales by Region (2023-2028) & (K Units)
Table 9. Global Cancer Biomarker Sales Market Share by Region (2023-2028)
Table 10. Global Cancer Biomarker Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Cancer Biomarker Revenue Market Share by Region (2017-2022)
Table 12. Global Cancer Biomarker Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Cancer Biomarker Revenue Market Share by Region (2023-2028)
Table 14. Global Cancer Biomarker Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Cancer Biomarker Sales Share by Manufacturers (2017-2022)
Table 16. Global Cancer Biomarker Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Cancer Biomarker Revenue Share by Manufacturers (2017-2022)
Table 18. Cancer Biomarker Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Cancer Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Cancer Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biomarker as of 2021)
Table 21. Cancer Biomarker Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Cancer Biomarker Product Offered
Table 23. Date of Manufacturers Enter into Cancer Biomarker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Biomarker Sales by Type (2017-2022) & (K Units)
Table 26. Global Cancer Biomarker Sales by Type (2023-2028) & (K Units)
Table 27. Global Cancer Biomarker Sales Share by Type (2017-2022)
Table 28. Global Cancer Biomarker Sales Share by Type (2023-2028)
Table 29. Global Cancer Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Cancer Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Cancer Biomarker Revenue Share by Type (2017-2022)
Table 32. Global Cancer Biomarker Revenue Share by Type (2023-2028)
Table 33. Cancer Biomarker Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Cancer Biomarker Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Cancer Biomarker Sales by Application (2017-2022) & (K Units)
Table 36. Global Cancer Biomarker Sales by Application (2023-2028) & (K Units)
Table 37. Global Cancer Biomarker Sales Share by Application (2017-2022)
Table 38. Global Cancer Biomarker Sales Share by Application (2023-2028)
Table 39. Global Cancer Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Cancer Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Cancer Biomarker Revenue Share by Application (2017-2022)
Table 42. Global Cancer Biomarker Revenue Share by Application (2023-2028)
Table 43. Cancer Biomarker Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Cancer Biomarker Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Cancer Biomarker Sales by Type (2017-2022) & (K Units)
Table 46. North America Cancer Biomarker Sales by Type (2023-2028) & (K Units)
Table 47. North America Cancer Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Cancer Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Cancer Biomarker Sales by Application (2017-2022) & (K Units)
Table 50. North America Cancer Biomarker Sales by Application (2023-2028) & (K Units)
Table 51. North America Cancer Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Cancer Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Cancer Biomarker Sales by Country (2017-2022) & (K Units)
Table 54. North America Cancer Biomarker Sales by Country (2023-2028) & (K Units)
Table 55. North America Cancer Biomarker Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Cancer Biomarker Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Cancer Biomarker Sales by Type (2017-2022) & (K Units)
Table 58. Europe Cancer Biomarker Sales by Type (2023-2028) & (K Units)
Table 59. Europe Cancer Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Cancer Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Cancer Biomarker Sales by Application (2017-2022) & (K Units)
Table 62. Europe Cancer Biomarker Sales by Application (2023-2028) & (K Units)
Table 63. Europe Cancer Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Cancer Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Cancer Biomarker Sales by Country (2017-2022) & (K Units)
Table 66. Europe Cancer Biomarker Sales by Country (2023-2028) & (K Units)
Table 67. Europe Cancer Biomarker Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Cancer Biomarker Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Cancer Biomarker Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Cancer Biomarker Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Cancer Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Cancer Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Cancer Biomarker Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Cancer Biomarker Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Cancer Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Cancer Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Cancer Biomarker Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Cancer Biomarker Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Cancer Biomarker Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Cancer Biomarker Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Cancer Biomarker Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Cancer Biomarker Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Cancer Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Cancer Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Cancer Biomarker Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Cancer Biomarker Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Cancer Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Cancer Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Cancer Biomarker Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Cancer Biomarker Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Cancer Biomarker Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Cancer Biomarker Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Cancer Biomarker Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Cancer Biomarker Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Cancer Biomarker Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Cancer Biomarker Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Cancer Biomarker Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Cancer Biomarker Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Cancer Biomarker Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Cancer Biomarker Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Cancer Biomarker Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Cancer Biomarker Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Cancer Biomarker Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Cancer Biomarker Revenue by Country (2023-2028) & (US$ Million)
Table 105. Thermo Fisher Scientific Corporation Information
Table 106. Thermo Fisher Scientific Description and Major Businesses
Table 107. Thermo Fisher Scientific Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Thermo Fisher Scientific Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Thermo Fisher Scientific Recent Developments
Table 110. Bio-Rad Laboratories Corporation Information
Table 111. Bio-Rad Laboratories Description and Major Businesses
Table 112. Bio-Rad Laboratories Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Bio-Rad Laboratories Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Bio-Rad Laboratories Recent Developments
Table 115. Roche Diagnostics Corporation Information
Table 116. Roche Diagnostics Description and Major Businesses
Table 117. Roche Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Roche Diagnostics Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Roche Diagnostics Recent Developments
Table 120. Qiagen Corporation Information
Table 121. Qiagen Description and Major Businesses
Table 122. Qiagen Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Qiagen Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Qiagen Recent Developments
Table 125. Illumina Corporation Information
Table 126. Illumina Description and Major Businesses
Table 127. Illumina Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Illumina Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Illumina Recent Developments
Table 130. GE Healthcare Corporation Information
Table 131. GE Healthcare Description and Major Businesses
Table 132. GE Healthcare Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. GE Healthcare Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. GE Healthcare Recent Developments
Table 135. Agilent Technologies Corporation Information
Table 136. Agilent Technologies Description and Major Businesses
Table 137. Agilent Technologies Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Agilent Technologies Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Agilent Technologies Recent Developments
Table 140. Biomérieux SA Corporation Information
Table 141. Biomérieux SA Description and Major Businesses
Table 142. Biomérieux SA Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Biomérieux SA Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Biomérieux SA Recent Developments
Table 145. Merck & Co. Corporation Information
Table 146. Merck & Co. Description and Major Businesses
Table 147. Merck & Co. Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Merck & Co. Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Merck & Co. Recent Developments
Table 150. Abbott Laboratories Corporation Information
Table 151. Abbott Laboratories Description and Major Businesses
Table 152. Abbott Laboratories Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Abbott Laboratories Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Abbott Laboratories Recent Developments
Table 155. Becton, Dickinson and Company Corporation Information
Table 156. Becton, Dickinson and Company Description and Major Businesses
Table 157. Becton, Dickinson and Company Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 158. Becton, Dickinson and Company Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Becton, Dickinson and Company Recent Developments
Table 160. Danaher Corporation Corporation Information
Table 161. Danaher Corporation Description and Major Businesses
Table 162. Danaher Corporation Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 163. Danaher Corporation Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Danaher Corporation Recent Developments
Table 165. Myriad Genetics Corporation Information
Table 166. Myriad Genetics Description and Major Businesses
Table 167. Myriad Genetics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 168. Myriad Genetics Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Myriad Genetics Recent Developments
Table 170. Sysmex Corporation Corporation Information
Table 171. Sysmex Corporation Description and Major Businesses
Table 172. Sysmex Corporation Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 173. Sysmex Corporation Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Sysmex Corporation Recent Developments
Table 175. Hologic Corporation Information
Table 176. Hologic Description and Major Businesses
Table 177. Hologic Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 178. Hologic Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Hologic Recent Developments
Table 180. Quest Diagnostics Corporation Information
Table 181. Quest Diagnostics Description and Major Businesses
Table 182. Quest Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 183. Quest Diagnostics Cancer Biomarker Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Quest Diagnostics Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Cancer Biomarker Distributors List
Table 188. Cancer Biomarker Customers List
Table 189. Cancer Biomarker Market Trends
Table 190. Cancer Biomarker Market Drivers
Table 191. Cancer Biomarker Market Challenges
Table 192. Cancer Biomarker Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of FiguresFigure 1. Cancer Biomarker Product Picture
Figure 3. Global Cancer Biomarker Market Share by Type in 2021 & 2028
Figure 3. Protein Biomarker Product Picture
Figure 4. Genetic Biomarker Product Picture
Figure 5. Global Cancer Biomarker Market Share by Application in 2021 & 2028
Figure 6. Diagnostics
Figure 7. Research
Figure 8. Others
Figure 9. Cancer Biomarker Report Years Considered
Figure 10. Global Cancer Biomarker Sales 2017-2028 (K Units)
Figure 11. Global Cancer Biomarker Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Cancer Biomarker Revenue 2017-2028 (US$ Million)
Figure 13. Global Cancer Biomarker Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Cancer Biomarker Sales Market Share by Region (2017-2022)
Figure 15. Global Cancer Biomarker Sales Market Share by Region (2023-2028)
Figure 16. North America Cancer Biomarker Sales YoY (2017-2028) & (K Units)
Figure 17. North America Cancer Biomarker Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Cancer Biomarker Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Cancer Biomarker Revenue YoY (2017-